Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Varicose vein laser treatment moves out of the OR

NCT ID NCT07629843

Symptom relief Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Aug 26, 2026 · Updated 3 times

Summary

This study will test a new way to treat varicose veins using a 1940nm laser, performed outside the operating room under local anesthesia. Researchers want to see how satisfied patients are with the procedure and check its safety and effectiveness. About 155 adults with saphenous vein issues will take part, and they will fill out a questionnaire to rate their experience.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
1940nm endovenous laser
What this could lead to
If successful, this could show that treating varicose veins with a laser outside the operating room is safe and satisfying for patients, potentially making the procedure more convenient.
What could go wrong
This is an observational study with no control group, so results may not prove the treatment is better than standard care. It is also early-stage and small (155 participants), so findings may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 155 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Jun 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population will be composed of adult patients receiving routine care for Endovenous Laser Ablation of primary or recurrent saphenous vein (great saphenous vein, small saphenous vein or anterior saphenous vein) outside the operating theater under strict local anesthesia.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥ 18 years. * Endovenous Laser Ablation of a common or recurrent saphenous vein as part of routine care. * Clinical, Etiology, Anatomy, Pathophysiology, classification clinical stage. * Ability to understand the study objectives and complete questionnaires in French. * Patient has been informed and has verbally indicated their non-opposition to participating in the research. Exclusion Criteria: * Endovenous Laser Ablation not feasible for technical reasons, particularly if the vein is too "bent" or there are endoluminal obstacles. * Episode of deep vein thrombosis less than 3 months ago or of superficial vein thrombosis less than 6 weeks ago. * Active cancer. * Geographical distance incompatible with study follow-up, according to the investigator's judgment. * Patients currently participating or having participated in research within the previous 3 months. * Persons covered by articles L1121-5 to L1121-8 of the French Public Health Code (corresponds to all protected persons: pregnant women, women in labor, breastfeeding mothers, persons deprived of liberty by judicial or administrative decision, persons subject to a legal protection measure).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Saphenous vein incompetence are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

varicose disease venous insufficiency

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Saphenous vein injury

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Institut de Pathologie Vasculaire - Hôpital Privé Geoffroy Saint-Hilaire

    Paris, 75005, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.